![]() |
Volumn 277, Issue 35, 2002, Pages 31789-31795
|
Mitochondria are direct targets of the lipoxygenase inhibitor MK886: A strategy for cell killing by combined treatment with MK886 and cyclooxygenase inhibitors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RESPIRATION;
CELLS;
ENZYME INHIBITION;
ENZYMES;
METABOLITES;
TUMORS;
BIOCHEMISTRY;
3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID;
ARACHIDONIC ACID;
CYTOCHROME C;
INDOMETACIN;
LIPOXYGENASE INHIBITOR;
PROSTAGLANDIN SYNTHASE INHIBITOR;
ARACHIDONIC ACID METABOLISM;
ARTICLE;
CANCER CELL CULTURE;
CELL DEATH;
COLON CANCER;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG TARGETING;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
LIVER MITOCHONDRION;
MITOCHONDRION;
PRIORITY JOURNAL;
PROSTAGLANDIN SYNTHESIS INHIBITION;
PROSTATE CANCER;
ANIMALS;
ARACHIDONIC ACID;
CELL DEATH;
CELL LINE;
CELL MEMBRANE PERMEABILITY;
CELL SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
INDOLES;
INDOMETHACIN;
INTRACELLULAR MEMBRANES;
LIPOXYGENASE INHIBITORS;
LIVER;
MALE;
MITOCHONDRIA, LIVER;
OXYGEN CONSUMPTION;
PERMEABILITY;
PROSTATIC NEOPLASMS;
RATS;
RATS, WISTAR;
TUMOR CELLS, CULTURED;
|
EID: 18544363407
PISSN: 00219258
EISSN: None
Source Type: Journal
DOI: 10.1074/jbc.M204450200 Document Type: Article |
Times cited : (60)
|
References (61)
|